Other

February 1, 2022

Press release - Non-regulatory

Targovax inngår forskningssamarbeid med Karolinska Institutet (Norwegian)

IR contact

Dr Lubor Gaal

Chief Financial Officer

(+34) 683 343 811

Renate Birkeli

Investor Relations

(+47) 922 61 624

Targovax ASA (OSE: TRVX) announced its third quarter 2022 results on Thursday 3 November 2022. Targovax’s management will present the results at a live streamed webcast at 10:00 am CET to investors, analysts and the press.

Report
Presentation
Webcast

Read the report

Targovax inngår forskningssamarbeid med Karolinska Institutet (Norwegian)

Dr Lubor Gaal

Chief Financial Officer

lubor.gaal@targovax.com

(+34) 683 343 811

Renate Birkeli

Investor Relations

renate.birkeli@targovax.com

(+47) 922 61 624

Targovax inngår forskningssamarbeid med Karolinska Institutet (Norwegian)

Subscribe